Clinical trials: Bifidobacterium Adolescentis PRL2019
Fibromyalgia, Fibromyalgia Syndrome
PRL2019 in the Treatment of Juvenile Fibromyalgia
Juvenile Fibromyalgia Syndrome (JFS) is a chronic condition affecting children and adolescents, characterised by widespread musculoskeletal pain and a significant impact on daily life and quality of life.
- Trial name
- IGG-microbiota (NCT07738926)
- Testing
- Bifidobacterium adolescentis PRL2019
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- Istituto Giannina Gaslini
Bifidobacterium Adolescentis PRL2019, IBS
Gabapral in Pediatric IBS
Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder (FGID) characterized by recurrent episodes of defecation related abdominal pain associated with abnormal bowel habit.
- Conditions
- Bifidobacterium Adolescentis PRL2019, IBS, Pediatric
- Trial name
- NCT05737277
- Testing
- Gabapral
- Volunteers
- 20 people
- Sponsor
- Azienda Ospedaliera "Sant'Andrea"